Laura Sue is an Endocrinology/Metabolic physician affiliated with Olive View-UCLA Medical Center. OpenAlex indexes 27 publications with 465 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
76.4%GLP-1 receptor agonist23.5%Trulicity48%Ozempic38%Mounjaro14%Part D<11 patientsBiguanide (metformin)18.8%Metformin Hcl61%Metformin Hcl Er39%Part D≥30 patients+ 4 more classes in this area
Hormonal (systemic)
13.3%l-Thyroxine10.4%Levothyroxine Sodium83%Synthroid17%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.6%Methimazole100%Part D<11 patients+ 1 more class in this area
Cardiovascular
10.4%Statin4.7%Atorvastatin Calcium100%Part D≥13 patientsACE inhibitor2.3%Lisinopril100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Finding the optimal glycemic target in sepsis using a joint longitudinal-survival model on the MIMIC-IV and eICU cohorts
Intelligence-Based Medicine
2026 - Optimizing blood glucose predictions in type 1 diabetes patients using a stacking ensemble approach
Endocrine and Metabolic Science
2025 - Comparison of machine learning models for predicting 30-day readmission rates for patients with diabetes
Journal of Medical Artificial Intelligence
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Sammy Saab, MD
Olive View-UCLA Medical Center
Sheba Meymandi, MD
Olive View-UCLA Medical Center
Glenn Mathisen, MD
Olive View-UCLA Medical Center
Bowen Chung, MD
Olive View-UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”